LIVI, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.286
EU - Europa 18.719
AS - Asia 13.335
SA - Sud America 1.763
Continente sconosciuto - Info sul continente non disponibili 501
AF - Africa 344
OC - Oceania 201
AN - Antartide 2
Totale 65.151
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.712
RU - Federazione Russa 6.185
IT - Italia 4.445
SG - Singapore 3.801
CN - Cina 3.401
PL - Polonia 2.776
HK - Hong Kong 1.928
BR - Brasile 1.388
IE - Irlanda 1.319
VN - Vietnam 1.240
SE - Svezia 1.125
KR - Corea 1.112
FR - Francia 680
DE - Germania 647
FI - Finlandia 469
IN - India 429
GB - Regno Unito 371
CA - Canada 355
BD - Bangladesh 317
JO - Giordania 252
UA - Ucraina 203
AU - Australia 196
ID - Indonesia 155
JP - Giappone 144
AR - Argentina 129
ES - Italia 125
TR - Turchia 97
NL - Olanda 95
IQ - Iraq 84
MX - Messico 82
CH - Svizzera 77
CI - Costa d'Avorio 62
EC - Ecuador 61
ZA - Sudafrica 55
NG - Nigeria 52
PK - Pakistan 49
CO - Colombia 46
VE - Venezuela 46
BE - Belgio 41
MA - Marocco 40
SA - Arabia Saudita 33
CZ - Repubblica Ceca 32
UZ - Uzbekistan 30
AE - Emirati Arabi Uniti 26
EG - Egitto 26
PH - Filippine 26
PE - Perù 24
CL - Cile 23
CR - Costa Rica 22
KE - Kenya 22
TN - Tunisia 22
PY - Paraguay 21
AZ - Azerbaigian 20
IL - Israele 20
KZ - Kazakistan 20
JM - Giamaica 19
LT - Lituania 19
TH - Thailandia 19
MY - Malesia 17
DO - Repubblica Dominicana 16
DZ - Algeria 16
HU - Ungheria 16
NP - Nepal 16
HN - Honduras 15
IR - Iran 14
TT - Trinidad e Tobago 14
UY - Uruguay 14
AT - Austria 13
BG - Bulgaria 13
PT - Portogallo 11
RO - Romania 11
SC - Seychelles 11
BJ - Benin 10
LB - Libano 10
SV - El Salvador 10
GR - Grecia 9
KG - Kirghizistan 9
NI - Nicaragua 9
BO - Bolivia 8
PA - Panama 8
SN - Senegal 8
TW - Taiwan 8
BH - Bahrain 7
OM - Oman 7
AL - Albania 6
SY - Repubblica araba siriana 6
ET - Etiopia 5
GT - Guatemala 5
MM - Myanmar 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
DK - Danimarca 4
DM - Dominica 4
EU - Europa 4
GE - Georgia 4
HR - Croazia 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
BB - Barbados 3
BW - Botswana 3
Totale 64.586
Salva come PNG Salva come JPEG
Città #
Santa Clara 5.383
Ashburn 3.690
Warsaw 2.754
Singapore 2.725
Fairfield 2.459
Hong Kong 1.637
Chandler 1.358
San Jose 1.348
Dublin 1.316
Woodbridge 1.126
Seoul 1.099
Seattle 1.081
Cambridge 976
Houston 954
Wilmington 802
Milan 774
Hefei 711
Beijing 693
Florence 511
Council Bluffs 499
Lawrence 443
Los Angeles 430
Altamura 421
Buffalo 414
Ann Arbor 413
Ho Chi Minh City 391
Princeton 359
Rome 352
Lauterbourg 320
The Dalles 311
Munich 293
Jacksonville 287
Hanoi 285
New York 280
Moscow 253
Paris 238
Boston 229
Mumbai 199
Shanghai 189
Melbourne 183
Helsinki 174
Phoenix 165
Medford 160
Dearborn 156
Dallas 154
Kent 152
Boardman 150
San Diego 144
São Paulo 137
Tokyo 127
Clifton 118
Naples 118
Toronto 91
London 88
Turin 88
Frankfurt am Main 87
Jakarta 86
Orem 83
Redondo Beach 73
Turku 73
Chicago 72
Bologna 70
Guangzhou 68
Abidjan 62
Bern 61
Montreal 61
Brooklyn 60
Falls Church 57
Barcelona 56
Da Nang 51
Denver 51
Figino 50
Atlanta 48
Chennai 48
Izmir 46
Norwalk 46
San Francisco 45
Abuja 44
Dong Ket 43
Miano 42
Genoa 40
Bengaluru 39
Stockholm 39
Brescia 38
Tianjin 37
Bari 36
Belo Horizonte 36
Brussels 36
Baghdad 34
Hillsboro 34
Palermo 34
Haiphong 33
Lappeenranta 33
Yubileyny 32
Johannesburg 31
Rio de Janeiro 31
Shenzhen 30
Brasília 29
Catania 29
Pune 29
Totale 42.371
Salva come PNG Salva come JPEG
Nome #
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 404
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two italian radiation oncology centers. I. the case of T1N0 disease. 375
Intravesical hyaluronic acid and chondroitin sulfate (Ialuril™) replenishment therapy for postradiation cystitis of prostate cancer: Results of a prospective pilot study 369
Sodium hyaluronate and chondroitin sulfate replenishment therapy can improve nocturia in men with post-radiation cystitis: results of a prospective pilot study 359
Quality of Life and Sexual Health in the Aging of PCa Survivors. 332
Head and neck reconstruction with pedicled flaps in the free flap era. 330
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. 329
Raccomandazioni cliniche per il carcinoma mammario 329
Hypofractionation in prostate cancer: radiobiological basis and clinical appliance. 326
Stereotactic body radiotherapy for cardiac and paracardiac metastases: University of Florence experience. 320
The Evolving Role of Ultrasound Guided Percutaneous Laser Ablation in Elderly Unresectable Breast Cancer Patients: A Feasibility Pilot Study 318
hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer. 311
A multiparametric method to assess the MIM deformable image registration algorithm 298
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 297
Therapeutic usability of two different fiducial gold markers for robotic stereotactic radiosurgery of liver malignancies: A pilot study 291
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 285
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy inmetastatic breast cancer: a retrospective analysis. 275
Breast cancer occurred after Hodgkin's disease: Clinico-pathological features, treatments and outcome: Analysis of 214 cases. 274
Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study 274
Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature. 273
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial 269
What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis 269
Operator-dependent reproducibility of size measurements of small phantoms and lung nodules examined with low dose thin-section 264
In Regard to Vaidya et al 261
Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy. 260
Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment 257
Radiosensitivity in the breast cancer management scenario: Another step forward? 255
PO-0643: Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer 255
A matched cohort study of radio-chemotherapy versus radiotherapy alone in soft tissue sarcoma patients 252
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 249
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. 247
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 246
Role of magnetic resonance imaging in the preoperative staging and work-up of patients affected by invasive lobular carcinoma or invasive ductolobular carcinoma 246
ADAM: A breathing phantom for lung SBRT quality assurance 243
Prognosis of men with penile metastasis and malignant priapism: a systematic review. 242
Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis 242
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial 240
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 238
ADAM phantom to test 4D medical imaging and dose delivery devices 233
Stereotactic vacuum-assisted breast biopsy: Comparison between 11- and 8-gauge needles 232
Cervicoisthmic choriocarcinoma mimicking cesarean section scar ectopic pregnancy 229
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 229
CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed 229
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer 227
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 225
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 224
Auto-planning for VMAT accelerated partial breast irradiation 223
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 223
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 221
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab 221
Influence of age and subtype in outcome of operable liposarcoma 221
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 219
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 219
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures 218
A case of metachronous double primary neuroendocrine cancer in pancreas/ileum and uterine cervix 217
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 217
Current trends and outcomes of breast reconstruction following nipple-sparing mastectomy: results from a national multicentric registry with 1006 cases over a 6-year period 216
AIRO Breast Cancer Group Best Clinical Practice 2022 Update 215
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 215
Microinvasive breast cancer: pathological parameters, cancer subtypes distribution, and correlation with axillary lymph nodes invasion. Results of a large single-institution series 215
Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery. 214
Bladder Instillation Therapy With Hyaluronic Acid and Chondroitin Sulfate Improves Symptoms of Postradiation Cystitis: Prospective Pilot Study 214
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 214
Alternating intravenous and oral vinorelbine plus epirubicin with pegfilgrastim as neoadjuvant treatment of locally advanced breast cancer. 213
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 213
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial 213
Accelerated intensity-modulated external radiotherapy as a new technical approach to treat the index quadrant after conserving surgery in early breast cancer: a preliminary study. 212
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial 211
Oral Lapacho-Based Medication: An Easy, Safe, and Feasible Support to Prevent and/or Reduce Oral Mucositis during Radiotherapy for Head and Neck Cancer 211
Breast cancer in the elderly: treatment of 1500 patients. 210
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 210
Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma. 209
The Italian Association for Radiotherapy and Clinical Oncology (AIRO) position statements for postoperative breast cancer radiation therapy volume, dose, and fractionation 208
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 208
Interim PET after Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 208
Methodological approach to create an atlas using a commercial auto-contouring software 208
Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer. 207
Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature 207
Role of core needle biopsy in primary breast lymphoma 205
Accelerated Partial Breast Irradiation with IMRT: New Technical Approach and Interim Analysis of Acute Toxicity in a Phase III Randomized Clinical Trial. 203
91P * DEFINITIVE CONCOMITANT RADIOCHEMOTHERAPY (RCT) TREATMENT FOR LOCALLY ADVANCED (LA) NON SMALL CELL LUNG CANCER (NSCLC): EVALUATION OF HEMATOLOGICAL AND ESOPHAGEAL TOXICITY IN THE RADIATION ONCOLOGY DEPARTMENT OF UNIVERSITY OF FLORENCE EXPERIENCE 203
Ribociclib plus letrozole and concomitant palliative radiotherapy for metastatic breast cancer 202
Radiomic and dosiomic profiling of paediatric medulloblastoma tumours treated with intensity modulated radiation therapy 202
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 202
Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy 201
A dosimetric comparison between CyberKnife and tomotherapy treatment plans for single brain metastasis 200
Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors? 200
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience 199
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 199
Radiotherapy in the age of cancer immunology: Current concepts and future developments 198
Use of tamoxifen in pT1a-pT1b, pN0 breast cancer. 198
Accelerated Partial Breast Irradiation: Florence Phase 3 Trial Experience and Future Perspectives 196
Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node 196
Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer 196
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 195
Analysis of skin dose distribution for the prediction of severe radiation dermatitis in head and neck squamous cell carcinoma patients treated with concurrent chemo-radiotherapy 195
Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO) 195
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 195
Axillary ultrasound scanning in the follow-up of breast cancer patients undergoing sentinel node biopsy. 195
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients 194
Totale 23.951
Salva come PNG Salva come JPEG
Categoria #
all - tutte 192.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 192.682
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.000 0 0 189 130 71 111 83 198 98 111 390 619
2022/20236.166 565 1.252 262 348 451 1.051 775 414 685 63 170 130
2023/20242.592 109 252 368 137 166 365 116 581 53 134 206 105
2024/202517.072 623 1.685 1.048 2.739 4.892 1.977 304 985 824 534 632 829
2025/202620.715 2.095 2.581 1.747 1.687 2.271 729 2.500 1.043 1.322 1.415 780 2.545
2026/20272.828 896 1.200 732 0 0 0 0 0 0 0 0 0
Totale 65.151